Search

everythinglearnresearchcommunity

for

Search:↓

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Blocking interferon-gamma might help treat various autoimmune diseases.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

The Enriched-GF method efficiently produces high-yield growth factors for tissue repair.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

KGF-1 135 is a stable and effective alternative for treating oral mucositis.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Four antibodies were developed to help study hair follicle cell differentiation.

Targeting specific T cells may help treat alopecia areata.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.